Advertisement

 

 

Human Genetics of Sclerosing Bone Disorders.

Human Genetics of Sclerosing Bone Disorders.
Author Information (click to view)

De Ridder R, Boudin E, Mortier G, Van Hul W,


De Ridder R, Boudin E, Mortier G, Van Hul W, (click to view)

De Ridder R, Boudin E, Mortier G, Van Hul W,

Advertisement

Current osteoporosis reports 2018 04 14() doi 10.1007/s11914-018-0439-7
Abstract
PURPOSE OF REVIEW
The group of sclerosing bone disorders encompasses a variety of disorders all marked by increased bone mass. In this review, we give an overview of the genetic causes of this heterogeneous group of disorders and briefly touch upon the value of these findings for the development of novel therapeutic agents.

RECENT FINDINGS
Advances in the next-generation sequencing technologies are accelerating the molecular dissection of the pathogenic mechanisms underlying skeletal dysplasias. Throughout the years, the genetic cause of these disorders has been extensively studied which resulted in the identification of a variety of disease-causing genes and pathways that are involved in bone formation by osteoblasts, bone resorption by osteoclasts, or both processes. Due to this rapidly increasing knowledge, the insights into the regulatory mechanisms of bone metabolism are continuously improving resulting in the identification of novel therapeutic targets for disorders with reduced bone mass and increased bone fragility.

Submit a Comment

Your email address will not be published. Required fields are marked *

18 + seven =

[ HIDE/SHOW ]